Manhattan Psychiatric Center

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Manhattan Psychiatric Center sits in the upper quartile of US sponsors by registered trial count (#1,806 of 15,742 sponsors by registered trial count).

7 total trials 1 currently recruiting 6 completed early-phase tilt upper quartile by trial count

Manhattan Psychiatric Center: 7 sponsored US clinical trials, 1 recruiting.

Manhattan Psychiatric Center sponsors 7 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 6 completed. 1 of these trials are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Schizoaffecitve Disorder, with 1 trials.

Upper-quartile sponsor footprint

Manhattan Psychiatric Center sits in the upper quartile of the sponsor corpus (#1,806 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.

Open and recent trials

7 total, page 1 of 1

RECRUITING NA

A Virtual Reality Mindfulness Application for Aggression in Schizophrenia

NCT07434479
COMPLETED NA

Transcranial Direct-current Stimulation (tDCS) in Treatment Refractory Auditory Hallucinations

NCT03485131
COMPLETED Phase 4

Equivalence of Generic Clozapine to Orally Dissolving Clozapine in Schizophrenia or Schizoaffective Disorder

NCT00501618
COMPLETED NA

Brain Activation Patterns in Schizophrenia After Computerized Cognitive Skills Training

NCT00431223
COMPLETED NA

Outcome Evaluation of Solutions for Wellness and Team Solutions Program in Patients With Severe Mental Illness

NCT00661869
COMPLETED Phase 2

High Dose of Quetiapine in Treating Subjects With Treatment Refractory Schizophrenia or Schizoaffective Disorder

NCT00297947
COMPLETED Phase 2

Effect of Ziprasidone on Glucose & Plasma Lipids in Diabetes (II) and Schizophrenia or Schizoaffective Disorder

NCT00395031

Phase Distribution

PhaseTrial count
Phase 2 2
Phase 4 1

Therapeutic Areas

Schizoaffecitve Disorder 1
Schizophrenia Disorder 1
Schizoaffective Disorder 1
Aggression 1
Schizophrenia 1

What is open in the Manhattan Psychiatric Center pipeline

1 recruiting of 7 indexed (14% open); 6 completed (86%).

Phase mix: 1 late (III/IV) vs 2 early (I/II) (early-phase heavy).

Top condition: Schizoaffecitve Disorder (1 trial), 4 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Manhattan Psychiatric Center: open-pipeline peers nationwide

Peers matched on 7 registered trials and 14% open enrollment, not the therapeutic-area sidebar.

Manhattan Psychiatric Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 01020304050 0%10%20%30%40% Total trials Recruiting share Manhattan Psychiatric Center3M4Life Research89bioAbbott Diagnostics DivisionAcademic and Community Cancer Research UnitedAdaptive BiotechnologiesAgelessRxAlaska Blind Child Discovery
Manhattan Psychiatric Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Manhattan Psychiatric Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 7 trials (± recruiting share)

Sponsors near 14% open enrollment (± trial volume)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Manhattan Psychiatric Center page

7 registered trials is a research-attention snapshot, not an endorsement of Manhattan Psychiatric Center or any single study.

  • 1 of Manhattan Psychiatric Center's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Schizoaffecitve Disorder is the condition Manhattan Psychiatric Center studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Schizoaffecitve Disorder trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Manhattan Psychiatric Center pipeline card: 7 registered trials from official public datasets.Report a data error.